Mechanistically, our gain and loss of function analyses have unveiled a notable downregulation of major MHC‐II molecules following RECQL4 overexpression, concomitant with alterations in the secretion of immune‐regulatory factors that foster an immunosuppressive tumour microenvironment. Here, RECQL4 is linked to neoplasm.